The Association of Biotechnology Companies BioForum launches the #polishbiotech online database as the largest association of biotech companies in Poland.
We are the first point of contact for entrepreneurs in the biotechnology industry and we constantly support the Polish biotechnology community 👩🔬 👨🔬
SIGN UP HERE 👇👇👇
"*" indicates required fields
USP Zdrowie sp. z o.o. (USP Group)
+ business areaBioPharma R&D+Services
+ annual revenue
2020 – 861,400,000 PLN
2021 – 903,800,000 PLN
2022 – 1,100,000,000 PLN
2023 – 1,300,000,000 PLN
2024 – 1,400,000,000 PLN
+ workforce (estimated if not reported)
2024 - 589
USP Zdrowie is a leading Polish pharmaceutical company that has been operating in the OTC segment for over 30 years. It manufactures and distributes well-known brands such as Apap, Ibuprom, Gripex, Verdin, Stoperan, and Xenna.